Related Experiment Video
Updated: Jul 4, 2025
08:15
Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue
Published on: October 8, 2016
7.4K
Soft Tissue Perivascular Epithelioid Cell Tumors
Phoebe M Hammer1, Serena Y Tan1
1Department of Pathology, Stanford University School of Medicine, 1291 Welch Road, Lane Building L235, Stanford, CA 94305, USA.
Surgical Pathology Clinics
|January 26, 2024
Summary
Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms. This review highlights recent clinicopathological and molecular advancements in PEComas, particularly those arising in soft tissues.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Perivascular epithelioid cell tumors (PEComas) represent a diverse group of mesenchymal neoplasms.
- These tumors exhibit a characteristic myomelanocytic immunophenotype.
- The PEComa family includes angiomyolipoma, lymphangioleiomyomatosis, and various rare neoplasms.
Purpose of the Study:
- To review recent clinicopathological findings in PEComas.
- To discuss molecular features and advancements in PEComa research.
- To focus on soft tissue PEComas.
Main Methods:
- Literature review of recent studies on PEComas.
- Analysis of clinicopathological and molecular data.
- Synthesis of current knowledge on soft tissue PEComas.
Main Results:
- Recent studies have expanded the understanding of PEComa heterogeneity.
- Molecular insights are refining diagnostic criteria and therapeutic targets.
- Soft tissue PEComas present unique diagnostic and management challenges.
Conclusions:
- Continued research is crucial for accurate diagnosis and treatment of PEComas.
- Understanding molecular pathways is key to developing targeted therapies.
- Further investigation into soft tissue PEComas is warranted.
